Background/Aims: Aggrecanase-1 (ADAMTS-4) and aggrecanase-2 (ADAMTS-5) are secreted enzymes belonging to the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family that play significant roles in the progression of osteoarthritis (OA). Here, we aimed to determine whether the expression of ADAMTS-4/5 in chondrogenesis and inflammation is regulated by microRNA-92a-3p (miR-92a-3p). Methods: MiR-92a-3p and ADAMTS-4/5 expressions were determined by quantitative polymerase chain reaction (qPCR). To investigate the repressive effect of miR-92a-3p on ADAMTS-4/5 expression, chondrogenic human mesenchymal stem cells (hMSCs) and human chondrocytes were transfected with mature miR-92a-3p or an antisense inhibitor (anti-miR-92a-3p), respectively. ADAMTS-4/5 protein production was quantified by enzyme-linked immunosorbent assay (ELISA), and miR92a-3p involvement in IL-1β-mediated catabolic effects was examined by immunoblotting. The roles of activated MAP kinases (MAPK) and nuclear factor (NF)-κB were evaluated by using specific inhibitors. Interaction between miR-92a-3p and its putative binding site in the 3′-untranslated region (3′-UTR) of ADAMTS-4/5 mRNA was confirmed by luciferase reporter assay. Results: miR-92a-3p expression was elevated in chondrogenic hMSCs, with significantly lower expression in OA cartilage than in normal cartilage. Stimulation with IL-1β significantly reduced miR-92a-3p expression in primary human chondrocytes (PHCs). Transfection of chondrocytes with miR-92a-3p downregulated IL-1β-induced ADAMTS-4/5 expression, and the activity of a reporter construct containing the 3′-UTR of human ADAMTS-4/5 mRNA.
MicroRNA

Introduction
Osteoarthritis (OA) is usually a progressive disease of the synovial joints that represents the failed repair of joint damage and ultimately results in the breakdown of cartilage and bone, leading to symptoms of pain, stiffness, and functional disability [1] [2] [3] It is widely accepted that the progression of OA is associated with proinflammatory cytokines derived from chondrocytes, such as interleukin (IL)-1β and tumor necrosis factor-α [4] . IL-1β activity can disrupt chondrocyte anabolism homeostasis via repressing the synthesis of proteoglycan and collagen [5, 6] . Proteoglycan and collagen degradation are principally carried out by members of the matrix metalloproteinase (MMP) family, such as MMP3, MMP7, and MMP13, which play important roles in degrading cartilage collagens [7] [8] [9] . However, previous biochemical studies have demonstrated that members of the a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family such as ADAMTS-1, -4, -5, -8, -9, and -15 possess aggrecanase activity and can induce the degradation of cartilage proteoglycan-aggrecan in OA [10] [11] [12] [13] [14] . Knockdown of ADAMTS-4/5 exerted protective effects against proteoglycan degradation and attenuated the severity of murine OA [15] , and the degradation of aggrecan was decreased when ADAMTS-4/5 small interfering RNA was used in human cartilage stimulated by IL-1β [16] . This finding suggested that both ADAMTS-4 and ADAMTS-5 are responsible for the aggrecan degradation in OA in humans. In support of this idea, recent studies have demonstrated that ADAMTS-4/5 are overexpressed in human OA cartilage, with a positive correlation with the degree of cartilage destruction [11, [17] [18] [19] [20] . These results suggest that ADAMTS-4/5 play a pivotal role in human OA cartilage and that their induction contributes to the development of OA. Aggrecanases are thus potential targets for the development of disease-modifying OA drugs (DMOADs).
MicroRNAs (miRNAs) are short endogenous oligonucleotides (~22 bp) that play a significant role in the regulation of post-transcriptional gene expression. MiRNAs regulate target gene expression by repressing mRNA translation and accelerating mRNA degradation [21, 22] . An increasing number of reports have demonstrated that miRNAs regulate chondrogenesis and cartilage development. For example, miR-445-3p regulates chondrogenic ATDC5 cells via inhibiting Runx2 [23] and modulates cartilage development and degeneration through modification of histone H3 acetylation [24] . Moreover, miR-125b [18] and miR-140 [20, 25] regulate ADAMTS-4 or ADAMTS-5 expression and the IL-1β-induced catabolic response in human chondrocytes, respectively.
We previously reported a 4.4-fold increase in miR-92a-3p expression when human adipose-derived stem cells were induced to differentiate into chondrocytes [26] . We also observed the rapid up-regulation of miR-92a-3p in chondrogenic human mesenchymal stem cells (hMSCs) beginning on day 7, which peaked at 21 days and was followed by a marked decrease in expression levels at day 28 [27] . In addition, the expression level of miR-92a-3p was significantly reduced in OA cartilage compared with that detected in normal cartilage [27] . In a luciferase reporter assay, we demonstrated that histone deacetylase 2 (HDAC2) was the target of miR-92a-3p [27] . However, using miRNA target prediction algorithms, we discovered that ADAMTS-4 and ADAMTS-5 may be potential targets of miR-92a-3p. Since miR-92a-3p and ADAMTS-4/5 are essential for mediating chondrocyte development and cartilage degeneration, we hypothesized that miR-92a-3p participates in OA pathogenesis by targeting and suppressing ADAMTS-4/5 expression.
To test this hypothesis, in the present study, we attempted to validate the regulation and molecular mechanism of miR-92a-3p in human chondrocytes. In particular, to investigate the repressive effect of miR-92a-3p on ADAMTS-4/5 expression, chondrogenic hMSCs and human chondrocytes were transfected with mature miR-92a-3p or an antisense inhibitor (anti-miR-92a-3p), respectively, and the potential involvement of miR-92a-3p in IL-1β-mediated catabolic effects was examined. Furthermore, we examined the potential molecular mechanism underlying this regulation by exploring the roles of activated mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κB using specific inhibitors, and determined the interaction between miR-92a-3p and its putative binding site in the 3′-untranslated regions (3′-UTRs) of ADAMTS-4/5 mRNA with a luciferase reporter assay. These findings might highlight miR-92a-3p as a novel regulator of cartilage homeostasis, indicating a candidate therapeutic target for OA.
Materials and Methods
This study adhered to the standards of the Ethics committee on Human Experimentation at the First Affiliated Hospital of Sun Yat-Sen University, China (IRB: 2011011) and the Helsinki Declaration (2000). All volunteers provided written informed consent.
Culture of hMSC
Bone marrow samples were harvested by iliac crest aspiration from six normal human donors (mean age: 37 years, range: 35-39 years, male: 3, female: 3). Density gradient centrifugation methods were used to isolate hMSCs [28] . In brief, the bone marrow was rinsed several times with sterile phosphate-buffered saline (PBS) before addition of Ficoll-Paque TM PLUS (GE Healthcare, Uppsala, Sweden), and centrifuged for 18 min at 1000 ×g. The interfacial mononuclear cells were collected and resuspended in hMSC basal medium (alpha-modified Eagle's medium; Gibco Life Technology Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS; Gibco Life Technology), and 1% penicillin/streptomycin (Gibco Life Technology). Cells from bone marrow aspirates were seeded at a density of approximately 50, 000 nucleated cells/cm 2 in a culture flask. The cells were cultured at 37°C in an atmosphere of 5% CO 2 . The medium was changed every 3 days. When the cultures were near 80% confluence, the cells were trypsinized with 0.05% trypsin/ ethylenediaminetetraacetic acid and passaged (1:2) in culture. The medium was refreshed every 3 days, and expanded cells at passage 3 or 5 were used for the experiments.
Chondrogenesis in a micromass culture
For micromass culturing, the cells were resuspended in incomplete chondrogenic induction medium (97 mL of hMSC chondrogenic differentiation basal medium, 10 μL of dexamethasone, 300 μL of ascorbate, I mL of ITS+ [insulin, transferrin, and selenium; BD Biosciences, Franklin Lakes, NJ, USA] supplement, 100 μL of sodium pyruvate, and 100 μL of proline; Cyagen, Guangzhou, China) at a specified density of 10 5 cells/ μL of medium, and droplets (12.5 µL) were then carefully added to each well of a 24-well plate. The hMSCs were allowed to adhere at 37°C for 70 min. Then, they were divided into two groups. The first group was cultured in incomplete chondrogenic induction medium and the second group was cultured in complete chondrogenic induction medium (10 µL of TGF-β3 was added to convert 1 mL of incomplete chondrogenic medium into complete medium; Cyagen); the medium was replaced every 3 days [29] .
Primary chondrocyte collection, isolation, and cell culture Cartilage tissues were harvested from OA knee joints during total knee replacement operation from patients (n = 8; mean ± standard deviation [SD] age: 65.8 ± 2.24 years; male: 4, female: 4). Normal cartilage tissues were collected from patients (n = 8; mean ± SD age: 64.4 ± 2.86 years; male: 4, female: 4) with no previous history of OA or RA, who underwent total hip replacement surgery because of fractures of the femoral neck. OA cartilage was collected from gross erosion areas, while normal cartilage was collected from areas with no surface irregularity. PHCs were isolated as described previously [30, 31] . The isolated chondrocytes were seeded in 75-cm 2 culture flasks and incubated in Dulbecco's modified Eagle's medium/ F12 (Gibco Life Technology) containing 5% FBS, 2% penicillin and streptomycin, and ITS+ premix. During the culture period, cells were incubated at 37°C in a humidified atmosphere of 5% CO 2 . The medium was changed every 2 days. following the manufacturer's instructions. qRT-PCR was performed using SYBR® Premix Ex Taq™ II (TAKARA Biotechnology) according to the manufacturer's instructions on a CFX96 system. The specific primers are listed in Table 1 . The relative gene expression levels were calculated using the 2 −ΔΔCt method. All experiments were performed at least in triplicate.
Transfection
The hMSCs and PHCs were transfected with an agomir or antagomir (RiboBio, Guangzhou, China) of miR-92a-3p at a concentration of 50 nM or 100 nM. Lipofectamine® 2000 Transfection Reagent (Gibco Life Technologies) was used to transfect cells according to the manufacturer's instructions. Non-specific microRNA (miR-Control; RiboBio) was used as a control.
Immunohistochemical analysis
Immunohistochemical analysis was performed as described previously [32] . Formalin-fixed and paraffin-embedded cartilage specimens were sectioned and stained with Safranin O for histological evaluation. In brief, sections were incubated for 10 min with 50 mL of 3% H 2 O 2 solution, and then incubated with primary anti-human ADAMTS-4 (1:200 dilution; Abcam, Cambridge, MA, USA) or ADAMTS-5 antibody (1:50; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) overnight at 4°C. Negative controls were prepared by substituting PBS for the primary antibody. The sections were then incubated with the secondary antibody horseradish peroxidase-conjugated anti-rabbit IgG (Cell Signaling Technology, Boston, USA) for 30 min
Western blot analysis
Western blotting was carried out as described previously [23] . Proteins were resolved on a 10% sodium dodecyl sulfate-polyacrylamide gel and transferred to polyvinylidene difluoride membranes (Millipore, Bedford USA). After blocking with 5% non-fat milk in Tris-buffered saline plus 0.1% Tween 20, the membranes were incubated with primary antibodies against ADAMTS-4 (1:1, 000; Abcam), ADAMTS-5 (1:200; Santa Cruz Biotechnology, Inc.), aggrecan (1:1, 000; Millipore), and β-actin (1:3, 000; Cell Signaling Technology). After washing, the blots were incubated with the corresponding secondary antibodies (Cell Signaling Technology) at room temperature for 1 h and visualized using an ECL chemiluminescence kit (Millipore).
ADAMTS-4 and ADAMTS-5 ELISA
Cells were stimulated with IL-1β for 24 h, and the ADAMTS-4 and ADAMTS-5 protein levels in the culture supernatants were quantified by ELISA using ADAMTS-4 and ADAMTS-5 immunoassay kits, according to the manufacturer's instructions (CusaBio, Wuhan, China). Plates were read at 450 nm using an HT Microplate Reader (BioTek, Winooski, VT, USA), and the ADAMTS-4 and ADAMTS-5 concentrations in the samples were calculated using a standard curve. 
Luciferase constructs and reporter assay
The pmiR-RB-REPORT™ luciferase vector (OBIO, Shanghai, China) was used for dual luciferase assays. The 3′-UTR fragments containing the predicted seed sequences were inserted into the vector using the XhoI/NotI restriction sites. The 3′-UTR fragments of the ADAMTS-4/5 coding sequences were PCR-amplified using the following primers: hsa-ADAMTS-4-3′-UTR-F, 5′ -ATAGGCCGGCATAGACGCGTCCTCACTATCCC-GGCTGC-3′, hsa-ADAMTS-4-3′-UTR-R, 5′-AAAGATCCTTTATTAAGCTTTGAGCACTTACTAGATGCTGAGTG-3′; hsa-ADAMTS-5(site1)-3′-UTR-F, 5′ -ATAGGCCGGCATAGACGCGTCCTGTGGTTATGATCTTATGCAC-3′, hsa-ADAMTS-5(site1)-3′-UTR-R, 5′-AAAGATCCTTTATTAAGCTTCAGTCTTATTAATATTAACCACTTTTTG-3′; hsa-ADAMTS-5(site2)-3′-UTR-F, 5′-ATAGGCCGGCATAGACGCGTCAACTTAACTGGCTAGTACATTG-3′, hsa-ADAMTS-5(site2)-3′-UTR-R, 5′-AAAGATCCTTTATTAAGCTTTACTTTAACCTAGTTTACAATTTATATTTAT-TATG-3′. The following primers were used for the mutated (mut) sequences: hsa-ADAMTS-4-mut-F, 5′-ATTGTGCACGATGTATCCAGCCTGGGCGACAG-3′, hsa-ADAMTS-4-mut-R: 5′-CTGGATACATCGTGCACAATCTC-GGCTCACTG-3′; hsa-ADAMTS-5(site1)-mut-F, 5′-ATAACTCCCAAGTTTTTCTAGCGACGTTGGTCACCACT-GTCACGTGAAG-3′; hsa-ADAMTS-5(site1)-mut-R, 5′-CCAACGTCGCTAGAAAAACTTGGGAGTTATTGAAC-3′; hsa-ADAMTS-5(site2)-mut-F, 5′-AATAACATAAATGCGACGTTAGCTTGAAAAAAAATCAGGCC-3′; and hsa-AD-AMTS-5(site2)-mut-R, 5′-AACGTCGCATTTATGTTATTGGTAAACACTTGGTG-3′. The resulting PCR products were digested and cloned into the pmiRs-RB-REPORT™ vector. For the dual luciferase assay, 1.2 × 10 4 cells (HEK293) in a 96-well plate were transfected with 50 nM miR-92a-3p or miR-NC (RibioBio) and 100 ng of vector. Luciferase activity was measured at 48 h post-transfection using the Dual-Luciferase ® Reporter Assay System (Promega, Madison, WI, USA). Firefly luciferase activity was then normalized to the corresponding Renilla luciferase activity.
Statistical analysis
All of the experiments were performed with at least three biological replicates. Data were evaluated as the mean ± SD. The Student t-test and Mann-Whitney U test were used to identify differences between groups as appropriate. P < 0.05 was considered statistically significant [33] . All analyses were performed using IBM SPSS Version 20 (IBM Corporation, Armonk, NY, USA).
Results
Expression patterns of ADAMTS-4/5 during the chondrogenic differentiation of hMSCs
To investigate the expression patterns of ADAMTS-4 and ADAMTS-5 during chondrogenesis, hMSCs were induced to differentiate into chondrocytes in vitro with transforming growth factor (TGF)-β3. ADAMTS-4/5 expression was significantly upregulated between days 21 and 35, (Fig. 1a A, B) . The expression of the chondrogenic marker aggrecan was first detected on day 7, which peaked at 21 days, followed by a marked decrease in expression at day 28 (Fig. 1a C) .
miR-92a-3p regulates the expression of ADAMTS-4/5 in hMSCs during chondrogenesis
To further investigate whether miR-92a-3p regulates ADAMTS-4/5 expression during chondrogenesis, miR-92a-3p was overexpressed or inhibited in the hMSCs. Monolayered hMSCs were transfected with either anti-miR-92a-3p or miR-92a-3p twice, one day after plating and again after 3 days, and were then induced to undergo chondrogenesis for 14 days (Fig. 1b) . Overexpression of miR-92a-3p significantly decreased the ADAMTS-4/5 expression level (Fig. 1b A, B and D) , and increased the aggrecan expression level (Fig. 1b C and D) . In contrast, the miR-92a-3p inhibitor markedly upregulated ADAMTS-4/5 expression (Fig.1b E,  F , and H) and downregulated aggrecan expression (Fig. 1b G and H) .
Expression of ADAMTS-4/5 in normal and OA cartilage
To assess the potential involvement of ADAMTS-4/5 in the progression of OA, we compared its expression level in normal and OA cartilage samples. Compared with normal cartilage, OA cartilage exhibited higher levels of ADAMTS-4/5 mRNA ( Fig. 2A and B) and protein ( Fig. 2C and D) , as assessed by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and immunohistochemical analysis, respectively. 
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Opposing expression between ADAMTS-4/5 and miR-92a-3p by IL-1β stimulation in human chondrocytes
Next, we evaluated the regulation of miR-92a-3p expression via IL-1β. Stimulation of chondrocytes with IL-1β resulted in decreased miR-92a-3p expression (Fig. 3A and D) , and increased levels of ADAMTS-4/5 mRNA (Fig. 3B, C , E, and F) and protein (Fig. 3G, H, I , and J) in a dose-and time-dependent manner. These results suggested that the reduced miR-92a-3p expression in response to IL-1β was correlated with increased ADAMTS-4/5 expression. 
Role of IL-1β signaling pathways in the regulation of miR-92a-3p and ADAMTS-4/5 expression in human chondrocytes
To investigate which signaling pathways of IL-1β regulate the expression of miR-92a-3p and ADAMTS-4/5, human chondrocytes were pretreated for 2 h with the NF-κB inhibitor SN50 or various MAPK inhibitors such as the MEK-1/2 inhibitor PD98059, p38 MAPK inhibitor SB203580, and JNK inhibitor SP600125, and then stimulated with IL-1β for 6 h (Fig.  4A , B, and C) or 24 h (Fig. 4D and E) . Compared with the expression levels in unstimulated controls, miR-92a-3p expression in IL-1β-stimulated primary human chondrocytes (PHCs) was decreased by 70.4%, while pretreatment with NF-κB and MAPK inhibitors attenuated the inhibitory effects of IL-1β on miR-92a-3p expression (Fig. 4A) . IL-1β stimulation induced an obvious increase in ADAMTS-4/5 mRNA and protein expression, while pretreatment with NF-κB and MAPK inhibitors suppressed the IL-1β-induced ADAMTS-4/5 expression in PHCs (Fig. 4B-E) . These results indicated that the IL-1β-stimulated activation of NF-κB and MAPK signaling pathways might be necessary for the suppressive effect of IL-1β on miR-92a-3p expression in PHCs.
Negative regulation of ADAMTS-4/5 expression by miR-92a-3p in humanchondrocytes
To verify whether IL-1β-responsive miR-92a-3p regulates ADAMTS-4/5 expression, PHCs were transfected with miR-92a-3p, miR-control, anti-miR-92a-3p, or anti-miR-control. Forty-eight hours after transfection, the cells were stimulated with IL-1β for 24 h. ADAMTS-4/5 mRNA expression was estimated by qRT-PCR, while ADAMTS-4/5 protein expression was estimated by enzyme-linked immunosorbent assay (ELISA) and western blotting. 
Figure 4
Overexpression of miR-92a-3p in PHCs significantly decreased the IL-1β-induced expression of ADAMTS-4/5 mRNA ( Fig. 5B and C) , while suppression of miR-92a-3p expression with anti-miR-92a-3p led to a significant increase in ADAMTS-4/5 mRNA expression ( Fig. 5E and  F) . In addition, overexpression of miR-92a-3p significantly decreased the IL-1β-induced production of ADAMTS-4/5 protein, as estimated by ELISA and western blotting (Fig. 5G, H , and Fig.6A ), while transfection with anti-miR-92a-3p significantly upregulated ADAMTS-4/5 expression. PHCs were transfected with miR92a-3p or non-specific control microRNA (miR-Control), and with anti-miR-92a-3p or anti-miR-Control, and then left unstimulated or stimulated with IL-1β for 24 h for qRT-PCR analysis respectively. Forty-eight hours after transfection with miR-92a-3p or miR-Control (A, B, C, G, H), or with antimiR-92a-3p or antimiR-Control (D, E, F, I, J), the expression levels of miR-92a-3p (A, D), ADAMTS-4 (B, E), and ADAMTS-5 (C, F) were determined by qRT-PCR, and AD-AMTS-4/5 protein production (G-J) in culture supernatants were determined by ELISA, respectively. U6 and GAPDH were used as internal controls for microRNA and mRNA analysis, respectively. Data are presented as means ± standard deviation of four samples. P-values were computed vs. non-stimulated controls (*P<0.05; **P<0.01; *** P<0.001) or IL-1β-stimulated controls (#P<0.05; ##P<0.01; ### P<0.001). Abbreviations: ADAMTS4, ADAM metallopeptidase with thrombospondin type 1 motif, 4; ADAMTS5, ADAM metallopeptidase with thrombospondin type 1 motif, 5; qRT-PCR, quantitative reverse-transcription polymerase chain reaction; ELISA, enzyme-linked immunosorbent assay. Abbreviations: ADAMTS4, ADAM metallopeptidase with thrombospondin type 1 motif, 4; ADAMTS5, ADAM metallopeptidase with thrombospondin type 1 motif, 5. (Fig. 5I, J, and Fig.6B ). These results suggested that ADAMTS-4/5 expression is downregulated by miR-92a-3p in human chondrocytes. 293T cells were transfected with luciferase reporters carrying the wild-type 3′-UTRs of ADAMTS-4, ADAMTS-5 site 1, or ADAMTS-5 site 2 (Luc-ADAMTS4-UTR, Luc-ADAMTS5-site1-UTR, and Luc-ADAMTS5-site2-UTR, respectively), or with vectors containing mutated 3′-UTR sequences in which the putative miR-92a-3p-binding site was altered (Luc-ADAMTS4-UTR-mut, Luc-ADAMTS5-site1-UTR-mut, and Luc-ADAMTS5-site2-UTR-mut, respectively) or in combination with miR-control or miR-92a-3p, respectively. Cells were harvested after 24 h, and luciferase activity was analyzed. Data are presented as means ± standard deviations from three independent experiments. *** P<0.001.
miR-92a-3p directly targets ADAMTS-4 and ADAMTS-5 by interaction with the 3′-UTR
On the basis of bioinformatics analysis with TargetScan and micro.RNA.org, ADAMTS-4 and ADAMTS-5 were identified as potential targets of miR-92a-3p. Furthermore, the qRT-PCR data demonstrated that ADAMTS-4/5 were regulated by miR-92a-3p. We therefore utilized a luciferase reporter assay to further examine whether the 3′-UTRs of ADAMTS-4/5 contain a sequence capable of interacting with miR-92a-3p. For these analyses, 293T cells were transfected with luciferase reporters containing wild-type or mutated 3′-UTRs from ADAMTS-4, ADAMTS-5 site 1, and ADAMTS-5 site 2 in the presence or absence of miR-92a-3p or the negative control. The putative miR-92a-3p-binding sites for the ADAMTS-4/5 mRNA molecules are shown in Fig. 7a . Notably, cells co-transfected with miR-92a-3p and vectors encoding the wild-type 3′-UTR sequences exhibited significantly lower luciferase activity than those co-transfected with the negative control and wild-type vectors, respectively. In contrast, there was no significant change in luciferase activity in cells co-transfected with miR-92a-3p and vectors in which the predicted miR-92a-3p-binding sites within the 3′-UTRs of ADAMTS-4/5 were mutated (Fig. 7b) . Together, these data indicate that miR-92a-3p does indeed modulate ADAMTS-4/5 expression by binding to the 3′-UTR of the respective sequences.
Discussion
It is widely accepted that ADAMTS-4/5 overexpression can play a key role in the destruction of cartilage in chronic joint diseases such as OA or rheumatoid arthritis (RA) [11-13, 15-17, 34-37] . In this study, we investigated miRNAs that are expressed in a differentiation-dependent pattern in hMSCs and articular chondrocytes. The combination of our previous research [27] and present results revealed that both miR-92a-3p and ADAMTS-4/5 have opposing expression patterns during the chondrogenic differentiation of hMSCs, especially during the late stage of chondrogenic differentiation, and that miR-92a-3p regulates ADAMTS-4/5 expression during chondrogenesis. We also demonstrated changes in the expression of miR-92a-3p in the cartilage of OA patients and in response to IL-1β stimulation. Specifically, miR-92a-3p expression was significantly decreased in OA cartilage compared with that in normal cartilage. The overexpression of miR-92a-3p suppressed IL-1β-induced ADAMTS-4/5 production, while transfection with anti-miR-92a-3p notably increased their production levels. Moreover, we demonstrated that ADAMTS-4/5, critical proteinases in OA pathogenesis, are regulated by miR-92a-3p. Mutation of the miR-92a-3p-binding site in the 3′-UTRs of ADAMTS-4/5 mRNA led to complete abrogation of the miR92a-3p-mediated repression of reporter activity, indicating that ADAMTS-4/5 are targets for miR-92a-3p-mediated repression.
Recent studies have reported the role of specific miRNAs in the pathogenesis of various diseases. Matsukawa et al. [18] reported that miR-125b acts as a direct regulator of ADAMTS-4 expression in human OA chondrocytes, and that the reduction of miR-125b expression in OA cartilage in response to IL-1β is closely related to enhanced production of ADAMTS-4. Moreover, it has been demonstrated that hsa-miR-15a exerts protective effects against OA by targeting ADAMTS-5 in human chondrocytes [19] .
MiR-92a is a component of the mir-17-92 cluster, which possesses oncogenic activity and can influence cell proliferation and tumorigenesis [38, 39] . Ning et al. [40] demonstrated a positive effect of miR-92a on the proliferation, differentiation, and survival of chondrogenic progenitor cells by targeting nog3, an inhibitor of the BMP signaling pathway. MiR-92a expression decreases rapidly in macrophages upon stimulation with Toll-like receptor ligands, and miR-92a controls the inflammatory response by targeting the MKK4/JNK/c-Jun pathway [41] . In our previous studies, we demonstrated that miR-92a-3p plays an important role in both cartilage development and degeneration via directly targeting HDAC2, and that siHDAC2 can also repress the expression of ADAMTS-4/5 in primary human chondrocytes [26, 27] .
Specifically, in our previous study [27] , when hMSCs were induced to differentiate into chondrocytes, miR-92a-3p expression was upregulated, especially during the early stage of chondrogenesis (days 14-21), but was subsequently down-regulated during hypertrophy and endochondral ossification (days 21-35) [27] . This expression pattern was quite similar to that of miR-140, which has been shown to stimulate chondrogenesis in vitro. In the present study, when hMSCs were induced to undergo chondrogenesis, overexpression of miR-92a-3p markedly suppressed ADAMTS-4/5 production and was associated with increased aggrecan expression, while suppression of miR-92a-3p enhanced ADAMTS-4/5 expression and was associated with reduced aggrecan expression [27] . Overall, these data suggest that miR-92a-3p regulates ADAMTS-4/5 expression during chondrogenesis.
IL-1β is an important regulator of joint inflammation and cartilage degradation in OA, and the present findings provide a link between IL-1β and miR-92a-3p. In OA cartilage, decreased miR-92a-3p expression and a concomitant increase in ADAMTS-4/5 expression were observed in our previous study [27] . Furthermore, when PHCs were stimulated with IL-1β, the expression of miR-92a-3p was significantly downregulated, similar to the effects observed with miR-125b [18] and miR-140 [25] , which have been shown to directly regulate the expression of ADAMTS-4 and ADAMTS-5, respectively, and enhanced production of ADAMTS-4/5 protein was noted. Our results also suggested that miR-92a-3p targets the seed sites of human ADAMTS-4 (nucleotide position 659-665) and ADAMTS-5 (nucleotide positions 195-201 and 5255-5261). This observation, along with the results of the luciferase reporter assay, indicates that miR-92a-3p probably interacts with the 3′-UTRs of ADAMTS-4/5 mRNA and downregulates their expression at the post-transcriptional level. In addition, in our study, the IL-1β-induced suppression of miR-92a-3p was reversed with treatment of NF-κB and MAPK inhibitors. A similar negative regulation of ADAMTS-4/5 in chondrocytes by activated NF-κB and MAPKs via miRNAs has been reported previously [42] [43] [44] [45] [46] , suggesting that miRNAs with similar functions in inflammation and degeneration may be regulated by a common set of catabolic pathways in chondrocytes, including NF-κB and MAPK.
The present study has some limitations. First, we did not elucidate the in vivo significance of miR-92a-3p. Second, the detailed signaling pathways involved in IL-1β-induced miR-92a-3p inhibition and the potential of miR-92a-3p as an OA marker remain to be investigated. Moreover, the results of the differential expression of miR-92a-3p were observed in a small sample (n = 8). A study involving a larger sample size is necessary to validate these findings.
In summary, we found that miR-92a-3p is downregulated by IL-1β, and may function as an important regulator of ADAMTS-4/5 in both chondrogenesis and OA pathogenesis. Further studies on miR-92a-3p have the potential to reveal important new regulatory pathways that control cartilage development and homeostasis and can provide the basis for novel therapeutic and/or preventive approaches for OA. 
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